Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with prader-willi syndrome

Journal of the Chinese Medical Association

Volumn 71, Issue 6, 2008, Pages 305-309

  Lin, Hsiang Yu ^a,b   Lin, Shuan Pei ^a,b,c   Tsai, Li Ping ^d   Chao, Mei Chyn ^e   Chen, Ming Ren ^a,b   Chuang, Chih Kuang ^a,f   Huang, Chi Yu ^a   Tsai, Fuu Jen ^g   Chou, I Ching ^g   Chiu, Pao Ching ^h   Huang, Cheng Hung ⁱ   Yen, Jui Lung ^j   Lin, Ju Li ^k   Kuo, Pao Lin ^l  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ CATHAY GENERAL HOSPITAL   (Taiwan)

^j TAIPEI CITY HOSPITAL   (Taiwan)

^k CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^l NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

more..

Author keywords

Growth hormone; Height; Obesity; Prader Willi syndrome; Rohrer index

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ARTICLE; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; FATALITY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRADER WILLI SYNDROME; RETROSPECTIVE STUDY; SCOLIOSIS; TAIWAN; TREATMENT DURATION;

EID: 48049083946     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70127-8     Document Type: Article

References (33)

1. Prader A, Labhart A, Willi H. Ein syndrome von adipositas, kleinwuchs, kryptorchismus und oligophreniee nach myatonieartigerm zustand im Neugeborenenalter. Schweiz Med Wochenschr 1956;86:1260-1.
2. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993;91:398-402.
3. Cassidy SB. Prader-Willi syndrome. J Med Genet 1997;34: 917-23.
4. Lin HY, Lin SP, Chuang CK, Chen MR, Yen JL, Lee YJ, Huang CY, et al. Genotype and phenotype in patients with Prader-Willi Syndrome in Taiwan. Acta Paediatr 2007;96: 902-5.
5. Lin HY, Lin SP, Yen JL, Lee YJ, Huang CY, Hung HY, Hsu CH, et al. Prader-Willi syndrome in Taiwan. Pediatr Int 2007;49: 375-9.
6. Lin HY, Lin SP, Lin CC, Tsai LP, Chen MR, Chuang CK, Huang CY. Polysomnographic characteristics in patients with Prader-Willi syndrome. Pediatr Pulmonol 2007;42:881-7.
7. Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 1996;9:393-400.
8. Thacker MJ, Hainline B, Dennis-Feezle L, Johnson NB, Pescovitz OH. Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency. Horm Res 1998;49:216-20.
9. Shaffer LG, Ledbetter DH, Lupski JR. Molecular cytogenetics of contiguous gene syndromes: mechanisms and consequences of gene dosage imbalance. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001:1291-324.
10. Lindgren AC, Hagenas L, Muller J, Blichfedt S, Rosenborg M, Brismar T, Ritzen EM. Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably. Acta Paediatr 1998;87:28-31.
11. Myers SE, Carrel AL, Whitman BY, Allen DB. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J Pediatr 2000;137:42-9.
12. Hauffa BP. One-year results of growth hormone treatment of short stature in Prader-Willi syndrome. Acta Paediatr Suppl 1997;423:63-5.
13. Lindgren AC, Hagenas L, Muller J, Bichfeldt S, Rosenborg M, Brismar T, Ritzen EM. Effects of growth hormone treatment on growth and body composition in Prader-willi syndrome: a preliminary report. Acta Paediatr Suppl 1997;423:60-2.
14. Eiholzer U, Weber R, Stutz K, Steinert H. Effect of 6 months of growth hormone treatment in young children with Prader-Willi syndrome. Acta Paediatr Suppl 1997;423:66-8.
15. Davies PS, Evans S, Broomhead S, Clough H, Day JME, Laidlaw A, Barnes ND. Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome. Arch Dis Child 1998;78:474-6.
16. Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, et al. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol (Oxf) 2006;65:178-85.
17. Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH. Effects of growth hormone on pulmonary function, sleep quality, behavior cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab 2003;88:2206-12.
18. Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab 2002;87:1581-5.
19. Eiholzer U, l'Allemand D. Growth hormone normalises height: prediction of final height and hand length in children with Prader-Willi syndrome after 4 years of therapy. Horm Res 2000; 53:185-92.
20. Lindgren AC, Ritzen EM. Five years of growth hormone treatment in children with Prader-Willi syndrome. Acta Paediatr 1999;55:109-11.
21. Eiholzer U, Schlumpf M, Nordmann Y, l'Allemand D. Early manifestations of Prader-Willi syndrome: influence of growth hormone. J Pediatr Endocrinol Metab 2001;14(Suppl):1441-5.
22. Obata K, Sakazume S, Yoshino A, Murakami N, Sakuta R. Effects of 5 years growth hormone treatment in patients with Prader-Willi syndrome. J Pediatr Endocrinol Metab 2003;16: 155-62.
23. Chen W, Tsai CY, Chen AC, Wu SF, Tin TW, Lin HC. Growth charts of Taiwanese youth: norms based on health-related physical fitness. Mid Taiwan J Med 2003;8(Suppl):85-93.
24. Yang SH, Cheng HH, Huang HY, Peng HC, Chen JW, Hsu HH, Shieh MJ. The body height and body weight of preschool children in Taipei city. Nutr Sci 2001;26:41-50.
25. Hsiao RL, Miau TS, Lu CC, Tsai CH, Lin MT, Wu CC, Lin MH, et al. A survey on weight and height of children (1 month - 7 years) and plotting of growth curves (1 month - 18 years) in Taiwan, 1987-1988. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1990;31:166-75. [In Chinese]
26. Reiter EO, Rosenfeld RG. Normal and aberrant growth. In: Williams Textbook of Endocrinology, 10th edition. Philadelphia: Saunders, 2003:1003-5.
27. Hindmarsh PC, Dattani MT. Use of growth hormone in children. Nat Clin Pract Endocrinol Metab 2006;2:260-8.
28. Allen DB. Growth hormone therapy for short stature: is the benefit worth the burden? Pediatrics 2006;118:343-8.
29. Shih KC, Ho LT, Kuo HF, Chang TC, Liu PC, Chen CK, Tiu CM. Linear growth response to recombinant human growth hormone in children with growth hormone deficiency. J Chin Med Assoc 1994;54:7-13.
30. Mei Z, Grummer-Strawn LM, Pietrobelli A, Goulding A, Goran MI, Dietz WH. Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. Am J Clin Nutr 2002;75: 978-85.
31. Himes JH. Anthropometric Assessment of Nutritional Status. New York: Wiley-Liss, Inc., 1991.
32. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM. Standardized percentile curves of body-mass index for children and adolescents. Am J Dis Child 1991;145:259-63.
33. Nagai T, Obata K, Tonoki H, Tenima S, Murakami N, Katada Y, Yoshino A, et al. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 2005;136:45-8.